Search Results

Palbociclib Isethionate 10 mg  | Purity Not Available

TargetMol

Palbociclib Isethionate (PD 0332991 isethionate) is a selective inhibitor of CDK4/6 (IC50s: 11/16 nM). It exhibits no inhibition against a panel of 36 additional protein kinases.

More Information Supplier Page

Palbociclib Isethionate 50 mg  | Purity Not Available

TargetMol

Palbociclib Isethionate (PD 0332991 isethionate) is a selective inhibitor of CDK4/6 (IC50s: 11/16 nM). It exhibits no inhibition against a panel of 36 additional protein kinases.

More Information Supplier Page

RGFP966 2 mg  | 99.77%

TargetMol

RGFP966 is an HDAC3 inhibitor (IC50: 0.08 μM) and does not affect other HDACs at concentrations up to 15 μM.

More Information Supplier Page

RGFP966 25 mg  | 99.77%

TargetMol

RGFP966 is an HDAC3 inhibitor (IC50: 0.08 μM) and does not affect other HDACs at concentrations up to 15 μM.

More Information Supplier Page

Ddr1-In-1 25 mg  | Purity Not Available

TargetMol

DDR1-IN-1 is an effective and specific DDR1 receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.

More Information Supplier Page

Ddr1-In-1 2 mg  | Purity Not Available

TargetMol

DDR1-IN-1 is an effective and specific DDR1 receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.

More Information Supplier Page

SANT-1 100 mg  | 100.00%

TargetMol

SANT-1 directly binds to Smoothened (Smo) receptor (Kd: 1.2 nM) and inhibits Smo agonist effects (IC50: 20 nM).

More Information Supplier Page

NSC 228155 50 mg  | 99.84%

TargetMol

NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.

More Information Supplier Page

NSC 228155 25 mg  | 99.84%

TargetMol

NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.

More Information Supplier Page